CNS repurposing-Potential new uses for old drugs: examples of screens for Alzheimer's disease, Parkinson's disease and spasticity
CG Parsons - Neuropharmacology, 2019 - Elsevier
Drug repurposing is recently gaining increasing attention, not just from pharmaceutical
companies but also from government agencies in an attempt to generate new medications to …
companies but also from government agencies in an attempt to generate new medications to …
CNS repurposing-Potential new uses for old drugs: Examples of screens for Alzheimer's disease, Parkinson's disease and spasticity
CG Parsons - Neuropharmacology, 2019 - pubmed.ncbi.nlm.nih.gov
Drug repurposing is recently gaining increasing attention, not just from pharmaceutical
companies but also from government agencies in an attempt to generate new medications to …
companies but also from government agencies in an attempt to generate new medications to …
CNS repurposing-Potential new uses for old drugs: Examples of screens for Alzheimer's disease, Parkinson's disease and spasticity.
CG Parsons - Neuropharmacology, 2018 - europepmc.org
Drug repurposing is recently gaining increasing attention, not just from pharmaceutical
companies but also from government agencies in an attempt to generate new medications to …
companies but also from government agencies in an attempt to generate new medications to …